The Enterprise Value as of November 2025 (TTM) for Aptose Biosciences Inc. (APTO) is 4.06M

According to Aptose Biosciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.06M. This represents a change of -74.68% compared to the average of 16.02M of the last 4 quarters.

Aptose Biosciences Inc. (APTO) Historical Enterprise Value (quarterly & annually)

How has APTO Enterprise Value performed in the past?

The mean historical Enterprise Value of Aptose Biosciences Inc. over the last ten years is 1.54B. The current 4.06M Enterprise Value has changed -73.62% with respect to the historical average. Over the past ten years (40 quarters), APTO's Enterprise Value was at its highest in in the March 2021 quarter at 7.90B. The Enterprise Value was at its lowest in in the September 2025 quarter at 5.31M.

Aptose Biosciences Inc. (APTO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aptose Biosciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aptose Biosciences Inc. (APTO) Average Enterprise Value

How has APTO Enterprise Value performed in the past?

The current Enterprise Value of Aptose Biosciences Inc. (APTO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aptose Biosciences Inc. (APTO) Enterprise Value vs. Peers

How is APTO’s Enterprise Value compared to its peers?

Aptose Biosciences Inc.’s Enterprise Value is less than Gamida Cell Ltd. (40.73M), greater than Rubius Therapeutics, Inc. (-13765000.00), greater than Idera Pharmaceuticals, Inc. (-11484000.00), greater than Nabriva Therapeutics plc (-7192677.00), less than Atreca, Inc. (36.62M), less than Gritstone bio, Inc. (43.29M), greater than Aravive, Inc. (-44467140.00), less than RVL Pharmaceuticals plc (16.09M), less than Oncorus, Inc. (42.71M), less than Affimed N.V. (8.04M),

Build a custom stock screener for Aptose Biosciences Inc. (APTO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptose Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aptose Biosciences Inc. (APTO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aptose Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.